Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.35
+0.280013.53%
Post-market: 2.31-0.0400-1.70%19:59 EDT
Volume:260.95K
Turnover:597.82K
Market Cap:39.67M
PE:-1.11
High:2.41
Open:2.09
Low:2.08
Close:2.07
Loading ...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024

GlobeNewswire
·
23 Oct 2024

NRX Pharmaceuticals Initiated at Buy by EF Hutton

Dow Jones
·
21 Oct 2024

NRx Pharmaceuticals initiated with a Buy at EF Hutton

TIPRANKS
·
21 Oct 2024

NRx Pharmaceuticals Leadership Shift and Strategic Governance Decisions

TipRanks
·
13 Oct 2024

BRIEF-Nrx Pharmaceuticals Inc Says Stephen Willard Resigns As CEO Of Nrx Pharmaceuticals

Reuters
·
12 Oct 2024

NRX Pharmaceuticals Inc: Stephen Willard Resigns as CEO of NRX Pharmaceuticals

THOMSON REUTERS
·
12 Oct 2024

Analysts Offer Insights on Healthcare Companies: Sequana Medical N.V (Frankfurt: DE:2SE), Palatin Technologies (PTN) and NRX Pharmaceuticals (NRXP)

TIPRANKS
·
08 Oct 2024

Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic

THOMSON REUTERS
·
03 Oct 2024

NRX Pharmaceuticals Inc - Acquisition Expected to Be Accretive to Revenue and Ebitda

THOMSON REUTERS
·
03 Oct 2024

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic

PR Newswire
·
03 Oct 2024

NRX Pharmaceuticals Completes 12-Month Stability Test for Ketamine Product

MT Newswires Live
·
30 Sep 2024

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)

THOMSON REUTERS
·
30 Sep 2024

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)

PR Newswire
·
30 Sep 2024